250 related articles for article (PubMed ID: 29720984)
1. Activation of Invariant Natural Killer T Cells Redirects the Inflammatory Response in Neonatal Sepsis.
Bolognese AC; Yang WL; Hansen LW; Sharma A; Nicastro JM; Coppa GF; Wang P
Front Immunol; 2018; 9():833. PubMed ID: 29720984
[TBL] [Abstract][Full Text] [Related]
2. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.
Li L; Yang J; Jiang Y; Tu J; Schust DJ
Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517
[TBL] [Abstract][Full Text] [Related]
3. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
[TBL] [Abstract][Full Text] [Related]
4. Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization.
Goto T; Ito Y; Satoh M; Nakamoto S; Nishizawa N; Hosono K; Naitoh T; Eshima K; Iwabuchi K; Hiki N; Amano H
Front Immunol; 2021; 12():754106. PubMed ID: 34691073
[TBL] [Abstract][Full Text] [Related]
5. Porcine Invariant Natural Killer T Cells: Functional Profiling and Dynamics in Steady State and Viral Infections.
Schäfer A; Hühr J; Schwaiger T; Dorhoi A; Mettenleiter TC; Blome S; Schröder C; Blohm U
Front Immunol; 2019; 10():1380. PubMed ID: 31316500
[TBL] [Abstract][Full Text] [Related]
6. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
Guan P; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
[TBL] [Abstract][Full Text] [Related]
7. CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice.
Gonzalez Roldan N; Orinska Z; Ewers H; Bulfone-Paus S
Eur J Immunol; 2016 Feb; 46(2):432-9. PubMed ID: 26564814
[TBL] [Abstract][Full Text] [Related]
8. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
[TBL] [Abstract][Full Text] [Related]
9. Human Invariant Natural Killer T cells possess immune-modulating functions during Aspergillus infection.
Beitzen-Heineke A; Bouzani M; Schmitt AL; Kurzai O; Hünniger K; Einsele H; Loeffler J
Med Mycol; 2016 Feb; 54(2):169-76. PubMed ID: 26483428
[TBL] [Abstract][Full Text] [Related]
10. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
11. The glycolipid exoantigen derived from Chlamydia muridarum activates invariant natural killer T cells.
Peng Y; Zhao L; Shekhar S; Liu L; Wang H; Chen Q; Gao X; Yang X; Zhao W
Cell Mol Immunol; 2012 Jul; 9(4):361-6. PubMed ID: 22728762
[TBL] [Abstract][Full Text] [Related]
12. Pathogen-expanded CD11b+ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1.
Han Y; Jiang Z; Chen Z; Gu Y; Liu Y; Zhang X; Cao X
J Autoimmun; 2015 Apr; 58():21-35. PubMed ID: 25592391
[TBL] [Abstract][Full Text] [Related]
13. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
[TBL] [Abstract][Full Text] [Related]
14. CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.
Zeissig S; Peuker K; Iyer S; Gensollen T; Dougan SK; Olszak T; Kaser A; Blumberg RS
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10449-10454. PubMed ID: 28893990
[TBL] [Abstract][Full Text] [Related]
15. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
[TBL] [Abstract][Full Text] [Related]
16. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
17. Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model.
Lee SW; Park HJ; Van Kaer L; Hong S; Hong S
Sci Rep; 2018 Jul; 8(1):10081. PubMed ID: 29973666
[TBL] [Abstract][Full Text] [Related]
18. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
19. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice.
Wu L; Parekh VV; Gabriel CL; Bracy DP; Marks-Shulman PA; Tamboli RA; Kim S; Mendez-Fernandez YV; Besra GS; Lomenick JP; Williams B; Wasserman DH; Van Kaer L
Proc Natl Acad Sci U S A; 2012 May; 109(19):E1143-52. PubMed ID: 22493234
[TBL] [Abstract][Full Text] [Related]
20. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
Yang G; Artiaga BL; Lewis ST; Driver JP
Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
